Anlon Healthcare has formally approved the acquisition of a majority stake in Remember India Health Links Private Limited through a board meeting held on April 16, 2026. The pharmaceutical company's board of directors unanimously approved this strategic acquisition to expand its operations and transform its business model.

Board Meeting Outcomes and Regulatory Disclosure

The board meeting, conducted at the company's registered office from 12:30 p.m. to 01:00 p.m. IST, approved the acquisition of 1,11,00,000 equity shares representing 63.98% of Remember India Health Links' equity share capital. The company has entered into a share purchase agreement dated April 16, 2026, with Remember India Health Links and its majority shareholders for this acquisition.

The company has made the necessary disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, to both BSE and NSE exchanges.

Target Company Profile and Financial Performance

Remember India Health Links Private Limited, incorporated on December 17, 2020, operates in the pharmaceutical manufacturing sector. The company specializes in manufacturing, processing, and dealing in pharmaceutical finished products including tablets and capsules.

Strategic Transformation Objectives

The acquisition represents a significant strategic shift for Anlon Healthcare, enabling transformation from an API manufacturer to a complete pharmaceutical provider. Through this acquisition, the company will expand across the pharmaceutical value chain by moving into finished dosage formulations while gaining access to more than 30 dossiers relating to finished dosage formulations.

The impact of the proposed acquisition is expected to extend across operational, financial and regulatory dimensions, facilitating integration of quality control processes, strengthening the financial profile, and enhancing market positioning from a B2B ingredient supplier to a broader pharmaceutical platform.

Transaction Structure and Timeline

The acquisition will be completed through cash consideration as specified in the share purchase agreement. The transaction is subject to completion of certain condition precedents and is expected to be completed within 4 to 5 months from the signing date. Upon completion, Remember India Health Links will become a subsidiary of Anlon Healthcare, providing the company with majority control and enhanced operational capabilities in the pharmaceutical sector.

Anlon Healthcare Limited has notified stock exchanges regarding the withdrawal of credit ratings by Brickwork Ratings India Private Limited for its bank loan facilities worth Rs.24.50 crores and term loans of Rs.10.36 crores.

Rating Withdrawal Details

The pharmaceutical company informed BSE and NSE on April 15, 2026, that Brickwork Ratings has withdrawn the credit ratings assigned to its bank loan facilities following the closure of certain facilities. The rating agency had previously reaffirmed and subsequently withdrawn the ratings due to facility closure.

Rating History and Process

Brickwork Ratings had initially reaffirmed a BWR C rating in November 2025 under the "Issuer not cooperating" category. Following the company's request for review and withdrawal dated May 30, 2025, the rating agency removed the ratings from the non-cooperating category and upgraded them to BWR BB+/Stable before withdrawing them entirely.

The company successfully obtained the No Objection Certificate and closure letter for the closed term loans from Punjab National Bank, MCC Rajkot, which facilitated the rating withdrawal process.

Regulatory Compliance

Anlon Healthcare Limited submitted this intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company noted that the rating rationale previously issued by Brickwork Ratings may not reflect its current position following the withdrawal.

Company Information

The communication was signed by Punitkumar Rasadia, Managing Director (DIN: 06696258), on behalf of Anlon Healthcare Limited. The company operates from its registered office at Silver Coin Complex, Kalawad Road, Rajkot, Gujarat, and trades on BSE with scrip code 544497 and NSE with symbol AHCL.